Month: March 2022

Tonight I tested positive to COVID-19.

I am experiencing flu-like symptoms and will be recovering over the next week.

I had tested myself daily since Sunday, including this morning, with all tests returning a negative result.

I took a further test this evening after developing a fever late today. The test was inconclusive so I took a PCR test tonight which returned a positive result late this evening.

I am continuing to follow health guidelines and am isolating at home in Sydney.

Jenny and the girls have thankfully tested negative but will isolate for seven days at home as close contacts.

While in isolation I will continue to discharge all my responsibilities as Prime Minister, including virtually chairing meetings of the National Security and Expenditure Review Committees of Cabinet, focusing on our emergency response to the devastating floods in Queensland and New South Wales, and ensuring we stand with each and every one of the affected communities both now and as the waters eventually recede.

I will also be focused on our urgent response to the tragedy unfolding in the Ukraine and Russia’s senseless aggression, staying in regular contact with our security and intelligence officials and our international partners, as well as working with the Treasurer to finalise the Budget.

Australia will provide significant additional military assistance and emergency humanitarian support to help the people of Ukraine following the brutal invasion by Russia.

Australia stands in solidarity with our friends and partners in supporting Ukraine and condemning Russia utterly for its unprovoked and unjustified attack on its neighbour.

Australia will provide around $70 million in lethal military assistance to support the defence of Ukraine, including missiles and weapons. We will also provide a range of non-lethal military equipment and medical supplies in response to a specific request from the Ukrainian Government.

Our contributions will complement actions taken by partners such as the United Kingdom, the United States, Canada, the European Union and other European nations – each of which we welcome. We will work with and through our closest partners and allies to supplement the already substantial support from the international community.

Australia will also commit immediate humanitarian assistance of an initial $35 million to help meet the urgent needs of the Ukrainian people. This assistance will deliver lifesaving services and supplies, including the provision of shelter, food, medical care and water.

Our lethal and non-lethal military assistance, along with our humanitarian funding, are in addition to the significant sanctions we have already imposed on Russia.

With the situation now seriously deteriorating after Russia’s invasion, current indications are that at least 160,000 people have been displaced inside Ukraine and around half a million people have fled to neighbouring countries. Numbers of displaced people will rise sharply as the security situation deteriorates further.

The cost of Russia’s aggression is being borne by innocent Ukrainians. This is a challenge the international community will meet, and Australia stands ready to provide further humanitarian assistance to support the people of Ukraine, including those fleeing to neighbouring countries.

Russia’s actions are a gross violation of international law and the UN Charter. There is no justification for these actions in Ukraine which are illegal, unjustified and unprovoked.

Following the Prime Minister of Australia’s announcement that Australia will provide defensive military assistance to Ukraine, a Royal Australian Air Force C-17A Globemaster III departed RAAF Base Richmond for Europe on 2 March 2022, carrying critical military equipment and medical supplies.

Australia will join other allies and partners to help the people of Ukraine to defend their nation, following Russia’s senseless and illegal invasion of Ukraine sovereignty.

Amidst devastating floods over east and growing calls for climate action, the Greens are urging Perth Festival, WA Youth Orchestra, and WA Symphony Orchestra to end their sponsorships with Woodside and Chevron and for the WA State Government to provide supplementary funding while new sponsors are secured. 

It comes as prominent West Australians and Perth Festival artists, including Tim Winton, Stella Donnelly, Fringe World performer Noemie Huttner-Koros, Kuruma Marthedunera woman and Murujuga traditional owner Josie Alec, and Nick Allbrook, lead singer of the band Pond, have each reportedly called for an end to this funding arrangement.

Australian Greens Senator for WA, Dorinda Cox said:

“It’s deeply disappointing that the Perth Festival – an event that is a huge highlight in our arts calendar – is being sponsored by companies like Woodside that profit from the destruction of our climate.”

“It’s not acceptable that this event is being sponsored by one of the nation’s biggest fossil fuel polluters. Woodside is drilling and blasting our oceans and with risky seismic surveys, and has plans for the development of the Scarborough Gas Project  – the biggest carbon bomb in our nation’s history. They shouldn’t get the opportunity to ‘greenwash’ and normalise their activities.

“Well done to those Perth Festival artists who have called this out, alongside Greenpeace Australia and 350 Perth and many others. We must keep fighting to change the corrupt political systems that continue to support exploring and burning fossil fuels for greed, a system that is cooking our planet and our oceans. We need everyone to stop these greedy corporations using opportunities to justify and elevate their dangerous activities.”

The Greens (WA) spokesperson for Climate Change, Dr Brad Pettitt MLC said:

“Woodside and Chevron alone are responsible for 14% of Australia’s total Scope 1 emissions and over a third of WA’s total annual emissions. As one of the largest exporters of LNG in the world and the only state in Australia with rising emissions, WA’s inaction will very literally have global implications.

“Just last night the IPCC released their 6th Assessment Report and it’s unequivocal: the climate delay and ‘smouldering dumpster fire of business as usual’ that governments like the McGowan and Morrison ones insist on is going to cost billions of people a livable future. This is far greater than politics now; our actions in the next 8 years will impact generations.

“From flooding in Queensland and New South Wales to heatwaves and bushfires in WA, the catastrophic effects of climate change are playing out in our backyards right now. 

“If we want any chance of mitigating the worst of climate change, we need to put an end to the influence that gas companies like Chevron and Woodside have had in our communities and politics for too long.

“We have all the technologies we need to address climate change, we just need different politicians. I want to be a part of the generation that acted for future generations while we still could, don’t you?

More than 35 allied health students each year will undertake placements and hands-on training in Katherine health clinics thanks to a grant from the Federal Coalition Government.

The new program will increase local access to occupational therapists, speech pathologists and social workers for patients in Katherine.

In addition to providing around 260 weeks of new placement opportunities for 36 students each year, three additional allied health clinicians and an Aboriginal allied health assistant will be employed.

Flinders University Northern Territory will receive $1.9 million in Federal funding from the Coalition Government for the Katherine Regional Collaborative Allied Health Placement Program.

Regional Health Minister, Dr David Gillespie visited the site today to meet local staff and make the announcement, that will help to improve the recruitment and retention of local allied health professionals.

“There is growing evidence that students who have a positive and rewarding extended training experience in a rural or remote area are more likely to take up rural practice upon graduation, which is what this site will help to provide for students,” Dr Gillespie said.

“A focus of the new allied health placement program will be to increase placement numbers of Aboriginal and Torres Strait Islander students undertaking their training in Katherine.”

Dr Gillespie said the project had strong local support. It is a partnership with Indigenous Allied Health Australia (IAHA) and two Aboriginal Community Controlled Health Organisations (ACCHOs) — Wurli-Wurlinjang and the Katherine West Health Board (KWHB).

Dr Gillespie said the partnership with Wurli-Wurlinjang will enable the employment of speech pathology and occupational therapy supervisors to support allied health students at its clinics.

Allied Health supervisors will be employed through Flinders University to supervise final-year allied health students within local health services.

The Aboriginal allied health assistant will be employed full-time to support the students and supervisors, and assist the team to work with local schools, families, community, and the health service to improve engagement, coordination and integrated care.

The site will also support the development of a Katherine-located IAHA Health Academy, mirroring its successful Darwin model.

It will also provide a scholarship for one allied health assistant traineeship, supported through the Academy and embedded into Wurli-Wurlinjang.

The partnership with KWHB will enable a part-time social work supervisor to be employed to join the social work team. Social work students will work under supervision as part of the team.

“Aboriginal and Torres Strait Islander students will be a priority and they will be guided by IAHA, which will mentor and support both supervisors and students on placement,” Dr Gillespie said.

“The local Katherine economy will get a boost too because along with the employment of more staff and the increase in students on placement, Flinders NT will purchase additional student accommodation and an 8-seater vehicle to transport students and supervision staff.”

Research into issues affecting older Australians has taken another step forward with the new national academic centre at Frankston Hospital – which will house the National Centre for Healthy Ageing – opening its doors today.

Through a partnership between the Government, Peninsula Health and Monash University, the academic centre will work towards transforming health service development, implementation, research and evaluation for older people, as well as those with addiction and mental health issues.

One of the key research points of the Centre will be to explore new and innovative ways to harness technology and data to help senior Australians remain independent.

Minister for Health and Aged Care, Greg Hunt, said the Centre will deliver better ways to care for elderly Australians, with successful models then able to be rolled out nationally.

“The Frankston and Mornington Peninsula has one of the fastest ageing populations in the country,” Minister Hunt said. “It is an ideal place to explore innovative health care solutions for older people, whether it be at home or in residential aged care.”

“Our Government is pleased to partner with Monash University and Peninsula Health to make the project a reality.”

“By delivering sustainable, evidence-based, efficient models of care, it will support people with increasingly complex health conditions to live their best lives.”

The Morrison Government invested $32 million in the healthy ageing component of the Centre, delivered through the $1.25 billion Community Health and Hospitals Program.

Supported by state-of-the-art ‘living labs’ for research activities and the latest technology, the new centre will help deliver the Government’s commitment to ensuring all Australians can access quality health care, when and where they need it.

Investing in health and medical research is a key pillar of the Morrison Government’s Long Term National Health Plan. Over the next four years, we will invest more than $6.6 billion in lifesaving health and medical research.

Australians will have access to four new medicines through the Pharmaceutical Benefits Scheme (PBS) from March 1 to help fight COVID-19, chronic graft versus host disease, leukaemia and a rare blood disease called paroxysmal nocturnal haemoglobinuria (PNH).

COVID-19 Treatment

From March 1, a prescription-only COVID-19 treatment will be available on the PBS for Australians highest risk of developing severe COVID-19.

Lagevrio® (molnupiravir) is an oral anti-viral medicine which can be used by patients with mild-moderate COVID- 19 who have a high risk for developing severe disease, reducing the need for admission to hospital.

Adults who have mild to moderate COVID-19 confirmed by a PCR or RAT verified by the prescribing doctor and who can start treatment within five days of symptom onset, can be prescribed PBS-subsidised Lagevrio by their doctor if:

• they are 65 years of age or older, with two other risk factors for severe disease (as increasing age is a risk factor, patients who are 75 years of age of older only need to have one other risk factor); or
• they identify as Aboriginal or Torres Strait Islander origin, and are 50 years of age or older with two other risk factors for severe disease, or
• they are moderately to severely immunocompromised.

A PBS listing for Lagevrio means eligible Australians can access this medicine from their local community pharmacy on a prescription from their doctor.

It is important that patients continue to follow local health guidance to isolate if they test positive for COVID-19, including using telehealth to see their doctor and asking their pharmacy to arrange for Lagevrio to be delivered at home, if necessary.

Graft versus host disease

Uvadex® (methoxsalen) is being listed on the PBS for the first time for Australians with chronic graft versus host disease (cGVHD), a complication that can occur when patients undergoing cancer treatment receive transplanted stem cells from a donor.

cGVHD is a complication of allogeneic stem cell transplant, that occurs when donor bone marrow or stem cells start recognising the recipient’s body as foreign and start attacking the recipient’s body cells.

This causes damage in the body, especially to the liver, skin and gut. cGVHD can appear immediately or any time after a patient’s allogeneic transplant.

Uvadex® will be used as part of an integrated, closed system extracorporeal photopheresis (ECP) service for the treatment of cGVHD.

ECP is a type of treatment which removes some of a patient’s blood using a machine. The machine separates the white blood cells—then red blood cells and plasma go back into the body.

The white blood cells are mixed with Uvadex^®, then exposed to ultraviolet (UV) light and put back into the patient.

The listing of Uvadex® on the PBS will benefit around 180 Australians a year, who without subsidy could pay more than $9,200 per course of treatment.

Leukaemia

Mylotarg^® (gemtuzumab ozogamicin) is also being listed for the first time for Australians with acute myeloid leukaemia (AML)

AML is a cancer of the blood and bone marrow in which the bone marrow makes immature white blood cells in high numbers. These abnormal cells crowd the bone marrow, preventing it from making normal blood cells.

AML is one of the rarer forms of cancer, accounting for 0.8 per cent of all cancers diagnosed, but it can occur at any age and is more common among adults over the age of 60.

Mylotarg^® is being listed for the first time for the treatment of patients with previously untreated de novo CD33-positve AML, for use in combination with standard intensive chemotherapy.

Mylotarg^® works by stopping the abnormal growth of these cells and destroying them.

The listing of Mylotarg^® on the PBS will benefit around 900 Australians a year, who without subsidy may pay around $18,000 per course of treatment.

Paroxysmal nocturnal haemoglobinuria

Australians with paroxysmal nocturnal haemoglobinuria (PNH)—a condition that produces defective blood cells—will have access to a new treatment, Ultomiris^® (ravulizumab).

PNH is a rare, potentially life-threatening condition in which red blood cells break apart prematurely. Symptoms occur because of the production of defective blood cells and because the bone marrow does not produce enough blood cells.

The specific symptoms and progression of the disorder vary greatly, and some individuals may have mild symptoms, which remain stable for many years; while others may have serious symptoms, which can progress to cause life-threatening complications. Blood clots are a very serious complication of PNH.

Ultomiris ^® protects the red blood cells from damage and destruction by blocking the body’s inflammatory response.

Ultomiris^® will be listed for the first time for patients with PNH and will benefit around 160 Australians a year, who without subsidy may pay around $550,000 per year for treatment.

At the same time, Soliris^® (eculizumab), which has been available through the Life Savings Drug Program for the treatment of PNH, will move to the PBS.

This PBS listing has been recommended by the independent Pharmaceutical Benefits Advisory Committee.

Minister for Health and Aged Care, Greg Hunt, said the Morrison Government’s commitment to ensuring Australians can access affordable medicines, when they need them, remains rock solid.

“Instead of paying thousands of dollars to access these treatments, from March 1, Australians will pay $42.50 per script, or as little as $6.80 with a concession card,” Minister Hunt said.

“Since 2013, the Coalition Government had approved more than 2,800 new or amended listings on the PBS. This represents an average of around 30 listings or amendments per month – or one each day – at an overall investment by the Government of $14.3 billion.”

This is a strong contrast to Albanese and Labor, who when last in Government stopped listing essential medicines and treatments on the PBS.